RXMD
shares have been trending higher over the past two months, forming a base with the potential to break out significantly higher on a move back above the $0.07 level. This follows another spectacular quarter with Q2 numbers out earlier this week. The company is also transitioning at the top spot, with a CEO change underway to position RXMD for an uplist onto a major exchange.